Shannon L Meeks (Shannon Meeks, S L Meeks)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 14

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Blood

Journal of clinical medicine

Nature biotechnology

Emory University

Duke University (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Emory University Sep 01 2015

United States

Associate Professor of Pediatrics :: Aflac Cancer and Blood Disorders Center

Emory University Sep 01 2009 - Aug 31 2015

United States

Assistant Professor of Pediatrics :: Aflac Cancer and Blood Disorders Center

Emory University Jul 01 2007 - Aug 31 2009

United States

Instructor :: Aflac Cancer and Blood Disorders Center

Education History

Duke University Aug 01 1993 - May 19 1997

United States

BSC :: Mathematics

Publications

Shannon L Meeks, Karen L Zimowski
Haemophilia in the era of novel therapies: Where do inhibitors feature in the new landscape? Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Shannon L Meeks, Karen L Zimowski
Haemophilia in the era of novel therapies: Where do inhibitors feature in the new landscape? Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Shannon L Meeks, Karen L Zimowski
Haemophilia in the era of novel therapies: Where do inhibitors feature in the new landscape? Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Duc Quang Tran, Craig C Benson, Judith A Boice, Meera B Chitlur, Amy L Dunn, Miguel A Escobar, Kalpna Gupta, Jill M Johnsen, James Jorgenson, Scott D Martin, Suzanne Martin, Shannon L Meeks, Alfredo A Narvaez, Doris V Quon, Mark T Reding, Ulrike M Reiss, Brittany Savage, Kim Schafer, Bruno U K Steiner, Courtney Thornburg, Lena M Volland, Annette von Drygalski
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia. Expert review of hematology 16 (sup1) (2023)
Birgit M Reipert, Christoph J Hofbauer, Bagirath Gangadharan, Verena Berg, Elizabeth Donnachie, Shannon L Meeks, Maria Elisa Mancuso, Joel Bowen, Deborah L Brown
Qualification of Hemophilia Treatment Centers to Enable Multi-Center Studies of Gene Expression Signatures in Blood Cells from Pediatric Patients. Journal of clinical medicine 12 (5) (2023)
Birgit M Reipert, Christoph J Hofbauer, Bagirath Gangadharan, Verena Berg, Elizabeth Donnachie, Shannon L Meeks, Maria Elisa Mancuso, Joel Bowen, Deborah L Brown
Qualification of Hemophilia Treatment Centers to Enable Multi-Center Studies of Gene Expression Signatures in Blood Cells from Pediatric Patients. Journal of clinical medicine 12 (5) (2023)
Steven W Pipe, Cedric Hermans, Meera Chitlur, Manuel D Carcao, Giancarlo Castaman, Joanna A Davis, Jonathan Ducore, Amy L Dunn, Miguel A Escobar, Janna Journeycake, Osman Khan, Johnny N Mahlangu, Shannon L Meeks, Ismail Haroon Mitha, Claude Négrier, Ulrike Nowak-Göttl, Michael Recht, Tammuella Chrisentery-Singleton, Oleksandra Stasyshyn, Kateryna V Vilchevska, Laura Villarreal Martinez, Michael Wang, Jerzy Windyga, Guy Aaron Young, W Allan Alexander, Daniel Bonzo, Christopher Macie, Ian S Mitchell, Evelyne Sauty, Thomas A Wilkinson, Amy D Shapiro
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors. Haemophilia : the official journal of the World Federation of Hemophilia 28 (4) (2022)
Glaivy Batsuli, Amanda Greene, Shannon L Meeks, Robert F Sidonio
Emicizumab in tolerized patients with hemophilia A with inhibitors: A single-institution pediatric cohort assessing inhibitor status. Research and practice in thrombosis and haemostasis 5 (2) (2021)
Connie M Arthur, Patricia E Zerra, Sooncheon Shin, Jianmei Wang, Xeuzheng Song, Christopher B Doering, Shannon L Meeks, Pete Lollar, Sean R Stowell
Non-Human Glycans Can Regulate Anti-FVIII Antibody Formation in Mice. Blood (2021)
Shannon L Meeks, Sébastien Lacroix-Desmazes
Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
Glaivy Batsuli, J Ito, R Mercer, W H Baldwin, C Cox, E T Parker, J F Healey, Pete Lollar, Shannon L Meeks
Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model. Journal of thrombosis and haemostasis : JTH 16 (9) (2018)
Philip M Zakas, Harrison C Brown, Kristopher Knight, Shannon L Meeks, H Trent Spencer, Eric A Gaucher, Christopher B Doering
Enhancing the pharmaceutical properties of protein drugs by ancestral sequence reconstruction. Nature biotechnology 35 (1) (2016)
Glaivy Batsuli, Wei Deng, John F Healey, Ernest T Parker, W Hunter Baldwin, Courtney Cox, Brenda Nguyen, Joerg Kahle, Christoph Königs, Renhao Li, Pete Lollar, Shannon L Meeks
High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors. Blood 128 (16) (2016)
Joshua Eubanks, W Hunter Baldwin, Rebecca Markovitz, Ernest T Parker, Courtney Cox, Christine L Kempton, Shannon L Meeks
A subset of high-titer anti-factor VIII A2 domain antibodies is responsive to treatment with factor VIII. Blood 127 (16) (2016)

Shannon L Meeks.css-eqlu8i{font-size:small;padding-left:4px;} (Shannon Meeks, S L Meeks)

Publication Activity (10 Years)

Top Topics

Top Venues

Shannon L Meeks (Shannon Meeks, S L Meeks)